Advances in Enzyme Regulation

Advances in Enzyme Regulation

1st Edition - July 10, 2003

Write a review

  • Editor: George Weber
  • Hardcover ISBN: 9780080442945

Purchase options

Purchase options
Sales tax will be calculated at check-out

Institutional Subscription

Free Global Shipping
No minimum order


This volume contains papers of 23 outstanding scientists who are working at the leading edge of metabolic regulation studies. Much of the volume focuses on novel aspects of signal transduction with emphasis on the role of phospholipase C in cell control mechanisms. One of the highlights of this volume is always the Special Symposium Lecture. This lecture was given for fifteen years by Nobel laureate, Sir Hans A. Krebs (UK) (now deceased). This year the Lecture was given by Nadir Maraldi, Director of the Laboratory of Cellular Biology and Electron Microscopy, University of Bologna, Italy. Professor Maraldi's presentation is on the important and novel subject of "Nuclear Proteins and Human Disease."

Table of Contents

  • Acknowledgements. List of Participants. Session I. Inositide Signaling: J.G. Cory. Re-examination of the significance of nuclear localization of PLC&bgr;1 in the likelihood of its involvement in neoplastic cell growth (L. Cocco, L. Manzoli et al.). The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatases (K. Backers, D. Blero, et al.). Session II. Drug targeting and resistance: L. Cocco. Inhibitors
    of diverse metabolic steps cause increased apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells that lack p53 expression: Convergence at Caspase-3 activation (A.H. Cory, C.C. Edwards et al.). Targeting signal transduction (G. Weber, F. Shen et al.). Session III. Tumor Metabolism: J.J. Starling. Utilization of the promoter region of the midkine gene as a tool to drive therapeutic genes in a tumor specific manner (S. Sakiyama, L. Yu et al.). Opportunities for studying cancer by metabolomics: Preliminary observations on tumors deficient in hypoxia-inducible factor 1 (J.R. Griffiths, M. Stubbs). Session IV. Control of Phospholipase: O. Greengard. Structural and mechanistic aspects of phosphoinositide C&ggr; regulation (M. Katan, R. Rodriguez et al.). Phospholipase C&dgr;: From
    genome structure to physiological function (K. Fukami, T. Inoue et al.). Activation of PI(4)P 5-kinase by small G proteins (Y. Kanaho, H. Miyazaki, M. Yamazaki). Session V. Oxidative Stress: N. Katunuma. Importance of phase 2 gene regulation in protection against electrophile
    and reactive oxygen toxicity and carcinogenesis (P. Talalay, A.T. Dinkova-Kostova, W.D. Holtzclaw). Ferritin regulation by oxidants and chemopreventive xenobiotics (J. Wilkinson, E.C. Pietsch IV et al.). Session VI. Regulation of gene expression: J.R. Griffiths. The regulation of adipocyte metabolism and gene expression by interleukin-11 (R. Tenney, J.R. Turnbull et al.). A comprehensive model for
    the allosteric regulation of class Ia ribonucleotide reductase (B.S. Cooperman, O.B. Kashlan). Raf kinases in lung tumor development (Rapp U.R., J. Fensterle et al.). Session VII. Regulation of Cell Proliferation: M. Stubbs. Interaction of cofilin with serine
    phosphatases PP1 and PP2A in normal and neoplastic human T
    lymphocytes (Y. Samstag, G. Nebl). Regulation of cell survival by
    atypical protein kinase C isozymes (H.H. Grunicke, M. Spitaler, et al.). Session VIII. Translocation and Activation: H.H. Grunicke. Regulation of cytosolic
    phospholipase A2 translocation (J.H. Evans, D.J. Fergus, C.C. Leslie). On the mechanism coupling phospholipase C&ggr;1 to
    the B- and T-cell antigen receptors (E. Bonvini, K.E. DeBel, et al.). Session IX. Evolutionary Analysis: R.A. Harris. Interpretive proteomics - Finding biological meaning in genome and proteome databases (S.A. Benner). Clostridum perfringens iota-toxin, ADP-ribosyltransferase: Structure and mechanism of action (J. Sakurai, M. Nagahama et al.). Session X. Signaling Pathway Interference: S.A. Benner. Dissection
    of signal-regulated transcriptional modules by signaling pathway
    interference in oncogene-transformed cells (R. Schäfer, O.I. Tchernitsa et al.). New cysteine protease
    inhibitors in physiological secretory fluids and their medical significance (N. Katunuma, A. Ohashi et al.). Session XI. Special Symposium Lecture: P. Talalay. At the nucleus of the problem: Nuclear proteins and disease (N.M. Maraldi, G. Lattanzi et al.). Author Index. Subject Index. Contents of Recent Volumes.

Product details

  • No. of pages: 486
  • Language: English
  • Copyright: © Elsevier Science 2003
  • Published: July 10, 2003
  • Imprint: Elsevier Science
  • Hardcover ISBN: 9780080442945

About the Editor

George Weber

Affiliations and Expertise

Indiana University School of Medicine, Indianapolis, USA

Ratings and Reviews

Write a review

There are currently no reviews for "Advances in Enzyme Regulation"